This is a completed but unpublished Phase 4 pragmatic trial of 3,959 participants examining vasopressin initiation thresholds in septic shock; results are not yet reported in this registry record.
Reported
Actual enrollment3,959
Primary outcome measure28-day all-cause mortality
Study phasePHASE 4